Novel Technologies for Vaccine Development

This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharm...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Lukashevich, Igor S. (Επιμελητής έκδοσης), Shirwan, Haval (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Vienna : Springer Vienna : Imprint: Springer, 2014.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Reverse Genetics Approaches for Rational Design of Inactivated and Live-Attenuated Influenza Vaccines
  • Viral-Vectored Vaccines to Control Pathogenic Filoviruses
  • Alphavirus Replicon Vectors for Prophylactic Applications and Cancer Intervention
  • Current Status and Future of Polio Vaccines and Vaccination
  • Current Status of Hantavirus Vaccines Development
  • Experimental DNA-Launched Live Attenuated Vaccines against Infections Caused by Flavi- and Alphaviruses
  • Sugar-Based Immune Adjuvants for Use in Recombinant, Viral, Vector, DNA and Other Styles of Vaccines
  • Adenovirus-based Vectors for the Development of Prophylactic and Therapeutic Vaccines
  • Radiovirotherapy for the Treatment of Cancer
  • TRICOM Poxviral-Based Vaccines for the Treatment of Cancer
  • The Use of Oncolytic Herpesvirus for the Treatment of Cancer
  • SA-4-1BBL; A Novel form of the 4-1BB Costimulatory Ligand as an Adjuvant Platform for the Development of Subunit Cancer Vaccines.